FindTrial
Sign In

Incidence of Pulmonary Embolism During Temporary Pacing Via Femoral Versus Subclavian Vein

Study of Incidence of Pulmonary Embolism During Peroperative Period of Temporary Pacing Via Femoral Vein Versus Subclavian Vein in China

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02430207
Enrollment
360
Registered
2015-04-30
Start date
2015-05-31
Completion date
Unknown
Last updated
2016-02-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pulmonary Embolism

Keywords

Pulmonary Embolism, Temporary Pacing, Femoral Vein, Subclavian Vein

Brief summary

Temporary pacing via femoral vein is used widely in mainland China, because of its feasibility and simplicity. However, pulmonary embolism often occurred after the procedure. It is not known that whether there was any difference in incidence of pulmonary embolism between via different approaches. This randomized and multi-center study was designed to verify whether temporary pacing via subclavian vein has lower incidence than via femoral vein.

Interventions

PROCEDUREtemporary pacing femoral vein

Temporary pacing via femoral or subclavian vein

PROCEDUREtemporary pacing subclavian vein

Sponsors

Suqian People's Hospital
CollaboratorUNKNOWN
The First People's Hospital of Kunshan
CollaboratorOTHER
Danyang People's Hospital of Jiangsu Province
CollaboratorUNKNOWN
Jiangsu Taizhou People's Hospital
CollaboratorOTHER
Xinghua People's Hospital
CollaboratorUNKNOWN
Jiangyin People's Hospital
CollaboratorOTHER
Qidong People's Hospital
CollaboratorUNKNOWN
Wuxi No. 2 People's Hospital
CollaboratorOTHER
Nantong No. 1 People's Hospital
CollaboratorUNKNOWN
Changzhou No.2 People's Hospital
CollaboratorOTHER
Xuzhou Medical University
CollaboratorOTHER
Jiangsu Province Hospital of Traditional Chinese Medicine
CollaboratorOTHER
Northern Jiangsu People's Hospital
CollaboratorOTHER
Rugao People's Hospital
CollaboratorOTHER
Xuzhou Central Hospital
CollaboratorOTHER
The First Affiliated Hospital with Nanjing Medical University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* 18 years old or older * There is indication for temporary pacing * Patients agreed to participate in the clinical trial and sign a written informed consent

Exclusion criteria

* History of pulmonary embolism or deep vein thrombosis * Devices existing in vein system * Patients who could not receive randomization * Severe coagulation disorder * Severe liver, kidney dysfunction * Mental diseases * Pregnancy * Patients investigators believed not suitable for enrollment

Design outcomes

Primary

MeasureTime frame
Percentage of participants suffering from pulmonary embolism12 hours to 7 days after extraction of temporary pacing leads

Secondary

MeasureTime frame
Percentage of participants suffering from deep vein thrombosis12 hours to 7 days after extraction of temporary pacing leads

Contacts

Primary ContactKai Gu, M.D.
gukaiwang@163.com0086 25 68136965

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026